Division News

  • Botten Lab Awarded Patents, Funds to Study RNA Viruses and Develop Novel Antiviral Strategies
    Jason Botten, Ph.D., professor of medicine and associate director of the Vermont Biomedical Research Network, received a University of Vermont SPARK-VT grant to help commercialize his work to develop broad-spectrum antiviral therapeutics, following a faculty pitch competition held in June 2022.
  • Teaching Academy Announces 2022 Frymoyer Scholars Projects & Investigators
    Three Larner College of Medicine faculty-led, interprofessional group projects have been selected to receive 2022 Frymoyer Scholars funding. The three projects focus on newborn resuscitation, building an interdisciplinary gender affirming care model, and fostering excellent clinical teachers, respectively.
  • Dr. Polly Parsons: Looking Back and Moving Forward
    On July 11, E.L. Amidon Chair and Professor of Medicine Polly Parsons, M.D., began the transition to her new role as President and CEO of the Alliance for Academic Internal Medicine (AAIM). We sat down with Dr. Parsons to reflect on her 16 years at the helm of the department, review her accomplishments and consider the department’s growth, struggles and triumphs.
  • VCCBH Symposium Highlights Early Career Investigators, Innovative Multidisciplinary Research
    More than 100 in-person and dozens of virtual participants attended the second annual Vermont Center for Cardiovascular and Brain Health (VCCBH) Symposium, held at the University of Vermont’s Davis Center June 2 to 3, 2022. The VCCBH, one of three National Institutes of Health Center of Biomedical Research Excellence-funded programs at UVM, is co-directed by Mary Cushman, M.D., M.Sc., professor and vice chair for emerging researchers in the Department of Medicine, and Mark Nelson, Ph.D., University Distinguished Professor and chair of the Department of Pharmacology.
  • Medical Class of 2022 Honors Night Recognizes Faculty, Students & Staff
    On May 13, the Larner College of Medicine at the University of Vermont held Honors Night for graduating medical students in the Class of 2022. Accolades presented included the Alpha Omega Alpha Honor Medical Society faculty, housestaff, and community physician awards; the Arnold P. Gold Foundation's Leonard Tow Humanism in Medicine faculty and student awards; Area Health Education Center Scholars; department awards to students; and awards from the Class of 2022.
  • Parsons Named President and CEO of Alliance for Academic Internal Medicine
    Polly Parsons, M.D., E.L. Amidon Chair and Professor of Medicine, has been named the next president and CEO of the Alliance for Academic Internal Medicine.
  • Dixon Named 2022-23 University Scholar
    Anne Dixon, M.A., BM BCh, professor of medicine, has been named one of four 2022-2023 University Scholars.
  • Inaugural Research Week Features Larner Faculty and Trainee Investigation & Innovation
    In celebration of its standing as a top 100 public research university, the University of Vermont held its first “Research Week” April 18 to 22 to showcase the work of faculty, student and trainee investigators. A number of Larner College of Medicine faculty and trainees received recognition and delivered presentations during the week's events.
  • Integrating Mental Health into Pediatric Primary Care
    UVM Pediatric Primary Care is removing barriers to mental health care with an evidence-based Primary Care Mental Health Integration program, piloted with support from the UVM Health Network.
  • Kirkpatrick Presents University Scholar Lecture on Combatting Global Infectious Diseases
    University of Vermont Chair of Microbiology and Molecular Genetics Beth Kirkpatrick, M.D., will present her 2021-22 University Scholar lecture on "Combatting Global Infectious Diseases: Vaccines and Human Models," on Monday, April 4, 2022.
  • CVRI Viridis Montis Challenge Highlights Early-Career Researchers
    Cardiac remodeling, chronic kidney disease, brain cell energy generation, hypertension and stroke risk, and socioeconomic status and cardiac rehabilitation outcomes, were the topics presented at the Cardiovascular Research Institute of Vermont’s annual Viridis Montis Early Career Investigator Challenge on February 2, 2022.
  • New Study Highlights Colorectal Cancer Treatments that Improve Patients' Quality of Life
    In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.
  • Heart Month: Bouncing Back after Atypical Heart Attack
    A heart attack struck 44-year-old Sara Rutledge during her daily run. Thanks to the competence and care of a team of clinicians at Central Vermont Medical Center and UVM Medical Center, she received a diagnosis for spontaneous coronary artery dissection - or SCAD - has had a successful recovery, and is back to doing her favorite activities.
  • Teaching Academy Snow Season Retreat Celebrates Medical Education Excellence
    University of Vermont Larner College of Medicine faculty, leaders, and colleagues gathered virtually for the Teaching Academy’s 2022 Snow Season Education Retreat January 20-21. Highlights of the two-day event included a plenary session by representatives of the Kern National Network for Caring and Character in Medicine, the Induction and Award Ceremony, and an in-person poster session.
  • Adrianzen Herrera Invested as Early Career Green & Gold Professor of Medicine
    In a ceremony held January 12, 2021, an outstanding early career physician-scientist in the University of Vermont’s Larner College of Medicine, Diego Adrianzen Herrera, M.D., was invested as the inaugural holder of the Early Career Green and Gold Professor of Medicine.
  • Carney & Levine Quoted in The Atlantic Article on COVID Surge in VT
    (NOVEMBER 24, 2021) Jan Carney, M.D., M.P.H., associate dean for public health and health policy, and Mark Levine, M.D., Vermont Commissioner of Health and professor of medicine, are both quoted in an article in The Atlantic, titled "America’s Pandemic Star Loses Some Luster," regarding the surge in COVID-19 cases in Vermont.
  • UVM Researchers Help Identify Impact of COVID-caused Delays in Breast Cancer Screening
    New research from U.S. Breast Cancer Surveillance Consortium (BCSC) members, including several University of Vermont researchers, found that from March to September 2020, breast biopsies and detected cancers at U.S. BCSC facilities dropped sharply, compared with the same span a year earlier.
  • UVM Invests Holcombe as Inaugural J. Walter Juckett Chair in Cancer Research
    With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
  • 2021 Celebration of Research Excellence Highlights Accomplishments at Larner
    The University of Vermont’s Larner College of Medicine held a successful Dean's Excellence in Research Celebration October 25-27, shining a light on the hard work and achievements of students, faculty, staff, and alumni.
  • Lahey Pens Opinion Piece on Booster Shots in STAT
    (OCTOBER 15, 2021) Tim Lahey, M.D., M.M.Sc., professor of medicine, authored a "First Opinion" column, titled "Feeling guilty about getting a booster shot? Here’s something you can do." The piece explores the fact that some people are reluctant to receive a booster shot due to vaccine equity issues.